These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 238492)

  • 1. [Isolation of surface antigens of influenza virus A/Hong Kong 1/68 (H3N2) by density gradient fractionation with a new carboxypolypeptidase (author's transl)].
    Bottex C; Chatot G; Fontanges R
    Arch Virol; 1975; 48(1):9-19. PubMed ID: 238492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of influenza virus neuraminidase with hemagglutinin activity and its comparison with that of viral neuraminidase.
    Arora DJ; Gabriel LF
    Biochim Biophys Acta; 1986 Oct; 884(1):73-83. PubMed ID: 3533157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of neuraminidase from hemagglutinins caused by treatment of influenza viruses with ether. (Brief report).
    Neurath AR; Rubin BA; Hartzell RW
    Arch Gesamte Virusforsch; 1969; 28(3):421-3. PubMed ID: 5386786
    [No Abstract]   [Full Text] [Related]  

  • 4. The polypeptides of influenza virus. 3. Identification of the hemagglutinin, neuraminidase and nucleocapsid proteins.
    Haslam EA; Hampson AW; Radiskevics I; White DO
    Virology; 1970 Nov; 42(3):566-75. PubMed ID: 5529977
    [No Abstract]   [Full Text] [Related]  

  • 5. Fractionation of the influenza virus with the object of producing subunit vaccine.
    Hoyle L; Barker SM
    Postgrad Med J; 1973 Mar; 49(569):193-4. PubMed ID: 4802482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polypeptides of influenza virus. 8. Large-scale purification of the hemagglutinin.
    Stanley P; Crook NE; Streader LG; Davidson BE
    Virology; 1973 Dec; 56(2):640-5. PubMed ID: 4796551
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective solubilization of hemagglutinin and neuraminidase from influenza viruses.
    Bachmayer H
    Intervirology; 1975; 5(5):260-72. PubMed ID: 1225862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus.
    Schulman JL; Kilbourne ED
    Proc Natl Acad Sci U S A; 1969 Jun; 63(2):326-33. PubMed ID: 5257124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid composition of polypeptides from influenza virus particles.
    Laver WG; Baker N
    J Gen Virol; 1972 Oct; 17(1):61-7. PubMed ID: 5084454
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1: Preparation and characterization of disrupted virions.
    Crawford CR; Mukhlis FA; Jennings R; Oxford JS; Hockley DJ; Potter CW
    Vaccine; 1984 Sep; 2(3):193-8. PubMed ID: 6531961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins.
    Brady MI; Furminger IG
    J Hyg (Lond); 1976 Oct; 77(2):161-72. PubMed ID: 1068195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 2 (N2) neuraminidase of the X-7 influenza virus recombinant: determination of molecular size and subunit composition of the active unit.
    Bucher DJ; Kilbourne ED
    J Virol; 1972 Jul; 10(1):60-6. PubMed ID: 5040386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on antigenic variation in influenza virus. Evidence for multiple antigenic determinants on the hemagglutinin subunits of A-Hong Kong-68 (H3 N2) virus and the A-England-72 strains.
    Laver WG; Downie JC; Webster RG
    Virology; 1974 May; 59(1):230-44. PubMed ID: 4133135
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrophoretic studies on influenza A2 virus and its components.
    Ivanicovà S
    Pathol Microbiol (Basel); 1973; 39(5):319-33. PubMed ID: 4125677
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of influenza virus neuraminidases: peptide changes associated with antigenic divergence between early and late N2 neuraminidases.
    Kendal AP; Kiley MP
    J Virol; 1973 Dec; 12(6):1482-90. PubMed ID: 4761727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polypeptides of influenza virus. VI. Composition of the neuraminidase.
    Lazdins I; Haslam EA; White DO
    Virology; 1972 Sep; 49(3):758-65. PubMed ID: 5072635
    [No Abstract]   [Full Text] [Related]  

  • 17. Morphology of the isolated hemagglutinin and neuraminidase subunits of influenza virus.
    Laver WG; Valentine RC
    Virology; 1969 May; 38(1):105-19. PubMed ID: 5784043
    [No Abstract]   [Full Text] [Related]  

  • 18. Separation and purification of the biological active viral components, hemagglutinin and nucleoprotein-neuraminidase from some influenza A2 strains.
    Alexandrescu M; Handrache L; Moroşanu V; Vancea G; Ionescu L; Colev A; Duda R; Duca M
    Rev Roum Inframicrobiol; 1971; 8(2):43-8. PubMed ID: 5164576
    [No Abstract]   [Full Text] [Related]  

  • 19. K2-tartarate gradient centrifugation in the isolation of purified influenza virus haemagglutinin after bromelain cleavage.
    Hils J; May A; Neubert G; Domnick E; Pohl G; Liebe C
    Acta Virol; 1983 Nov; 27(6):470-6. PubMed ID: 6140831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the antigenicity of influenza virus aluminum oxide adjuvant vaccine "Alorbat" in man (author's transl)].
    Desselberger U; Pressler K; Erdmann G
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):160-77. PubMed ID: 1179878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.